Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,622 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 376
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +2.5%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 1,301–1,350 of 1,622 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03047525	Study of DC-CTL Combined With CIK for Advanced Solid Tumor	unknown	Phase 1 / Phase 2	200	Xiaoyi HuangOTHER	1	Feb 9, 2017	clinicaltrials
NCT01441765	PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine	terminated	Phase 2	11	Beth Israel Deaconess Medical CenterOTHER	1	Feb 8, 2017	clinicaltrials
NCT02273752